103 related articles for article (PubMed ID: 22974292)
1. 3D-QSAR studies on a series of 2,4-thiazolidinedione derivatives: a self- organizing molecular field analysis approach to design novel PTP 1B inhibitors.
Malla P; Kumar M
Med Chem; 2013 Sep; 9(6):828-45. PubMed ID: 22974292
[TBL] [Abstract][Full Text] [Related]
2. Self-organizing molecular field analysis of 2,4-thiazolidinediones: A 3D-QSAR model for the development of human PTP1B inhibitors.
Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
Eur J Med Chem; 2010 Jun; 45(6):2537-46. PubMed ID: 20236737
[TBL] [Abstract][Full Text] [Related]
3. Sulphonamides as inhibitors of protein tyrosine phosphatase 1B: a three-dimensional quantitative structure-activity relationship study using self-organizing molecular field analysis approach.
Thareja S; Kokil GR; Aggarwal S; Bhardwaj TR; Kumar M
Chem Pharm Bull (Tokyo); 2010 Apr; 58(4):526-32. PubMed ID: 20410637
[TBL] [Abstract][Full Text] [Related]
4. 2,4-Thiazolidinediones as PTP 1B Inhibitors: A Mini Review (2012-2018).
Verma SK; Yadav YS; Thareja S
Mini Rev Med Chem; 2019; 19(7):591-598. PubMed ID: 30968766
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR studies on a series of 5-arylidine-2, 4-thiazolidinediones as aldose reductase inhibitors: a self-organizing molecular field analysis approach.
Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
Med Chem; 2010 Jan; 6(1):30-6. PubMed ID: 20402658
[TBL] [Abstract][Full Text] [Related]
6. Cheminformatics based 3D-QSAR study on a series of 1,2-naphthoquinone derivatives as PTP 1B inhibitors.
Pahwa P; Papreja M
Acta Pol Pharm; 2012; 69(3):535-43. PubMed ID: 22594268
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of thiazolidine-2,4-dione/benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): Antihyperglycemic activity with molecular docking study.
Hidalgo-Figueroa S; Estrada-Soto S; Ramírez-Espinosa JJ; Paoli P; Lori G; León-Rivera I; Navarrete-Vázquez G
Biomed Pharmacother; 2018 Nov; 107():1302-1310. PubMed ID: 30257345
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase 1B inhibitors: a molecular level legitimate approach for the management of diabetes mellitus.
Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
Med Res Rev; 2012 May; 32(3):459-517. PubMed ID: 20814956
[TBL] [Abstract][Full Text] [Related]
9. Quantitative structure-activity relationship (QSAR) and design of novel ligands that demonstrate high potency and target selectivity as protein tyrosine phosphatase 1B (PTP 1B) inhibitors as an effective strategy used to model anti-diabetic agents.
Arthur DE; Ejeh S; Uzairu A
J Recept Signal Transduct Res; 2020 Dec; 40(6):501-520. PubMed ID: 32397858
[TBL] [Abstract][Full Text] [Related]
10. Validation of formylchromane derivatives as protein tyrosine phosphatase 1B inhibitors by pharmacophore modeling, atom-based 3D-QSAR and docking studies.
Malla P; Kumar R; Kumar M
Chem Biol Drug Des; 2013 Jul; 82(1):71-80. PubMed ID: 23506477
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors.
Mahapatra MK; Kumar R; Kumar M
Bioorg Chem; 2017 Apr; 71():1-9. PubMed ID: 28126289
[TBL] [Abstract][Full Text] [Related]
12. Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking.
Khan MF; Azad CS; Kumar A; Saini M; Narula AK; Jain S
Bioorg Med Chem Lett; 2016 Apr; 26(8):1988-92. PubMed ID: 26965864
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR Studies on a Series of 5-Arylidine-2, 4-Thiazolidinediones as Aldose Reductase Inhibitors: A Self-Organizing Molecular Field Analysis Approach.
Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
Med Chem; 2010 Mar; ():. PubMed ID: 20218967
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and docking study of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as inhibitors of protein tyrosine phosphatase 1B.
Wang Z; Liu Z; Lee W; Kim SN; Yoon G; Cheon SH
Bioorg Med Chem Lett; 2014 Aug; 24(15):3337-40. PubMed ID: 24953600
[TBL] [Abstract][Full Text] [Related]
15. 3D QSAR studies on 1, 3, 4-thiadiazole derivatives: an approach to design novel anticonvulsants.
Thareja S; Aggarwal S; Verma A; Bhardwaj TR; Kumar M
Med Chem; 2010 Jul; 6(4):233-8. PubMed ID: 20843285
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and 3D-QSAR studies of imidazolidine-2,4-dione derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Wang MY; Jin YY; Wei HY; Zhang LS; Sun SX; Chen XB; Dong WL; Xu WR; Cheng XC; Wang RL
Eur J Med Chem; 2015 Oct; 103():91-104. PubMed ID: 26342135
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
[TBL] [Abstract][Full Text] [Related]
18. An amalgamated molecular dynamic and Gaussian based 3D-QSAR study for the design of 2,4-thiazolidinediones as potential PTP1B inhibitors.
Biharee A; Singh Y; Kulkarni S; Jangid K; Kumar V; Jain AK; Thareja S
J Mol Graph Model; 2024 Mar; 127():108695. PubMed ID: 38118354
[TBL] [Abstract][Full Text] [Related]
19. Human protein tyrosine phosphatase 1B inhibitors: QSAR by genetic function approximation.
Sachan N; Kadam SS; Kulkarni VM
J Enzyme Inhib Med Chem; 2007 Jun; 22(3):267-76, 371-3. PubMed ID: 17674807
[TBL] [Abstract][Full Text] [Related]
20. Validation of TZD Scaffold as Potential ARIs: Pharmacophore Modeling, Atom-based 3D QSAR and Docking Studies.
Dahiya L; Mahapatra MK; Kaur R; Kumar V; Kumar M
Comb Chem High Throughput Screen; 2017; 20(4):310-320. PubMed ID: 28302016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
